SCHEMBL17138351

SCHEMBL17138351

CC(C)(C)c1ccccc1[SiH](Br)Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
CA2 P00918 1/20 0.41
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
KIF11 P52732 1/20 0.34
ALOX12 P18054 1/20 0.33
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30
GRIN2C Q14957 1/20 0.30
GRIN3A Q8TCU5 1/20 0.30
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988385 0.78 ALDH1A1 (0.46) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL272815 0.76 ALDH1A1 (0.50) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL450655 0.76 TDP1 (0.44) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL3298464 0.74 ALDH1A1 (0.43) TDP1ALDH1A1TSHRCA2GABRA1
Bromomethane SCHEMBL28461678 0.73 ALDH1A1 (0.57) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL2101133 0.73 ALDH1A1 (0.41) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL5000032 0.73 TDP1 (0.41) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL2102113 0.73 ALDH1A1 (0.41) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL29355273 0.73 ALDH1A1 (0.63) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL580584 0.73 ALDH1A1 (0.63) TDP1ALDH1A1TSHRCA2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104974184-B preparation of silazane Compounds 信越化学工业株式会社 2019-12-06 CN disclosed
EP-2930177-B1 PREPARATION OF SILAZANE COMPOUND SHINETSU CHEMICAL CO (JP) 2018-04-25 EP disclosed
US-9416147-B2 Preparation of silazane compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-08-16 US disclosed
EP-2930177-A1 Preparation of silazane compound Shin-Etsu Chemical Co., Ltd. (JP) 2015-10-14 EP disclosed
US-20150284414-A1 PREPARATION OF SILAZANE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284414-A1 PREPARATION OF SILAZANE COMPOUND SLTM, SKP2, BCAT2 TDP1 3655/4885ALDH1A1 2132/4885TSHR 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.